Establishment & characterization of lymphoblastoid cell lines from patients with multiple primary neoplasms in the upper aero-digestive tract & healthy individuals

Indian Journal of Medical Research

Volumn 135, Issue 6, 2012, Pages 820-829

  Hussain, Tabish ^a   Kotnis, Ashwin ^a   Sarin, Rajiv ^a   Mulherkar, Rita ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Epstein barr virus; Lymphoblastoid cell lines; Multiple primary neoplasia; Ploidy analysis; Population doubling

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA CONTENT; EPSTEIN BARR VIRUS; FEMALE; GASTROINTESTINAL TUMOR; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOBLASTOID CELL; LYMPHOCYTE; MALE; SIGNAL TRANSDUCTION; UPPER AERO DIGESTIVE TRACT MULTIPLE PRIMARY NEOPLASM; UPPER GASTROINTESTINAL TRACT;

ADULT; AGED; B-LYMPHOCYTES; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; DIGESTIVE SYSTEM NEOPLASMS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MIDDLE AGED; RESPIRATORY TRACT NEOPLASMS;

EID: 84865350278     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Rao DN, Ganesh B. Estimate of cancer incidence in India in 1991. Indian J Cancer 1998; 35: 10-18.
2. Jhavar S, Sarin R, Mulherkar R, Benner A, Agarwal JP, Dinshaw K. Glutathione S-transferase M1 or T1 null genotype as a risk factor for developing multiple primary neoplasms in the upper aero-digestive tract, in Indian males using tobacco. Oral Oncol 2004; 40: 84-91.
3. Kotnis A, Sarin R, Mulherkar R. Genotype, phenotype and cancer: role of low penetrance genes and environment in tumour susceptibility. J Biosci 2005; 30: 93-102.
4. Rydzanicz M, Wierzbicka M, Gajecka M, Szyfter W, Szyfter K. The impact of genetic factors on the incidence of multiple primary tumors (MPT) of the head and neck. Cancer Lett 2005; 224: 263-278.
5. Meschini R, Berni A, Ortenzi V, Mancinelli P, Palitti F. Relation between DNA repair, apoptosis and chromosomal aberrations in presence of pifthrin-alpha, an inhibitor of p53. Mutat Res 2010; 701: 92-97.
6. Patel BP, Trivedi PJ, Brahmbhatt MM, Shukla SN, Shah PM, Bakshi SR. Mutagen sensitivity in oral cancer patients, healthy tobacco chewers and controls. Acta Cytol 2010; 54: 169-174.
7. Podhorecka M, Halicka HD, Klimek P, Kowal M, Dmoszynska A. Thalidomide induces phosphorylation of histone H2AX and increases rate of apoptosis caused by fudarabine in malignant lymphocytes of chronic lymphocytic leukemia in short-term cell cultures. Leuk Res 2009; 33: 997-1000.
8. Neitzel H. A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum Genet 1986; 73: 320-326.
9. Sie L, Loong S, Tan EK. Utility of lymphoblastoid cell lines. J Neurosci Res 2009; 87: 1953-1959.
10. Bernacki SH, Beck JC, Muralidharan K, Schaefer FV, Shrimpton AE, Richie KL, et al. Characterization of publicly available lymphoblastoid cell lines for disease-associated mutations in 11 genes. Clin Chem 2005; 51: 2156-2159.
11. Tan XL, Moyer AM, Fridley BL, Schaid DJ, Niu N, Batzler AJ, et al. Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy. Clin Cancer Res 2011; 17: 5801-5811.
12. Sugimoto M, Tahara H, Ide T, Furuichi Y. Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Res 2004; 64: 3361-3364.
13. Kennedy DO, Agrawal M, Shen J, Terry MB, Zhang FF, Senie RT, et al. DNA repair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer. J Natl Cancer Inst 2005; 97: 127-132.
14. Motykiewicz G, Faraglia B, Wang LW, Terry MB, Senie RT, Santella RM. Removal of benzo(a)pyrene diol epoxide (BPDE)-DNA adducts as a measure of DNA repair capacity in lymphoblastoid cell lines from sisters discordant for breast cancer. Environ Mol Mutagen 2002; 40: 93-100.
15. Sturgis EM, Clayman GL, Guan Y, Guo Z, Wei Q. DNA repair in lymphoblastoid cell lines from patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 1999; 125: 185-190.
16. Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990; 323: 795-801.
17. Kotnis A, Kannan S, Sarin R, Mulherkar R. Case-control study and meta-analysis of SULT1A1 Arg213His polymorphism for gene, ethnicity and environment interaction for cancer risk. Br J Cancer 2008; 99: 1340-1347.
18. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, et al. Primer-directed enzymatic amplifcation of DNA with a thermostable DNA polymerase. Science 1988; 239: 487-491.
19. Mishell BB, Shiigi SM. Selected methods in cellular immunology. San Francisco: Freeman and Co.; 1980. p. 16-19.
20. Satoh M, Yasuda T, Higaki T, Goto M, Tanuma S, Ide T, et al. Innate apoptosis of human B lymphoblasts transformed by Epstein-Barr virus: modulation by cellular immortalization and senescence. Cell Struct Funct 2003; 28: 61-70.
21. Kudoh A, Fujita M, Zhang L, Shirata N, Daikoku T, Sugaya Y, et al. Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment. J Biol Chem 2005; 280: 8156-8163.
22. Miller G, Shope T, Lisco H, Stitt D, Lipman M. Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. Proc Natl Acad Sci USA 1972; 69: 383-387.
23. Steck K, el-Naggar A. Solid tumor DNA ploidy analysis. Methods Mol Biol 1998; 91: 181-195.
24. Shankey TV, Rabinovitch PS, Bagwell B, Bauer KD, Duque RE, Hedley DW, et al. Guidelines for implementation of clinical DNA cytometry. International Society for Analytical Cytology. Cytometry 1993; 14: 472-477.
25. Takebayashi S, Ogawa T, Jung KY, Muallem A, Mineta H, Fisher SG, et al. Identifcation of new minimally lost regions on 18q in head and neck squamous cell carcinoma. Cancer Res 2000; 60: 3397-3403.
26. Sandoval N, Platzer M, Rosenthal A, Dork T, Bendix R, Skawran B, et al. Characterization of AT M gene mutations in 66 ataxia telangiectasia families. Hum Mol Genet 1999; 8: 69-79.
27. Cloos J, de Boer WP, Snel MH, van den Ijssel P, Ylstra B, Leemans CR, et al. Microarray analysis of bleomycin-exposed lymphoblastoid cells for identifying cancer susceptibility genes. Mol Cancer Res 2006; 4: 71-77.
28. Dirksen EH, Cloos J, Braakhuis BJ, Brakenhoff RH, Heck AJ, Slijper M. Human lymphoblastoid proteome analysis reveals a role for the inhibitor of acetyltransferases complex in DNA double-strand break response. Cancer Res 2006; 66: 1473-1480.
29. Watters JW, Kraja A, Meucci MA, Province MA, McLeod HL. Genome-wide discovery of loci infuencing chemotherapy cytotoxicity. Proc Natl Acad Sci USA 2004; 101: 11809-11814.
30. Wu TY, Fridley BL, Jenkins GD, Batzler A, Wang L, Weinshilboum RM. Mycophenolic acid response biomarkers: a cell line model system-based genome-wide screen. Int Immunopharmacol 2011; 11: 1057-1064.